Clinical Trials Browser

Phase 1 × Pancreatic Neoplasms × Bendamustine Hydrochloride × Clear all

NCT04809766 2025-04-20

Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Phase 1 Terminated

Gastrointestinal

Pancreatic Neoplasms